Recent Original Publications in Peer Reviewed Journals:
Hollander E, Soorya L, Chaplin W, Anagnostou E, Taylor BP, Ferretti CJ, Wasserman S, Swanson E, Settipani C. A Double-Blind Placebo-Controlled Trial of Fluoxetine for Repetitive Behaviors and Global Severity in Adult Autism Spectrum Disorders. Am J Psychiatry. 2012 Mar 1;169(3):292-9.
Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Moller HJ, WFSBP Task Force on Mental Disorders in Primary Care; WPSBP Task Force on Anxiety Disorders, OCD and PTSD. Guidelines for the pharmacological treatment of axiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract. 2012 Jun; 16(2):77-84.
Pallanti S, Di Rollo A, Antonini S, Cauli G, Hollander E, Quercioli L. Low-frewunecy rTMS over right dorsolateral prefrontal corext in the treatment of resistant depression: cognitive improvement is independent from clinical response, resting motor threshold is related to clinical response. Neuropsychobiology. 2012 Jun; 65(4):227-35.
Fan J, Bernardi S, Dam NT, Anagnostou E, Gu X, Martin L, Park Y, Liu X, Koloevzon A, Soorya L, Grodberg D, Hollander E, Hof PR. Functional Deficits of the attentional networks in autism. Brain Behav. 2012 Sep; 2(5):647-60.
Anagnostou E, Soorya L, Chaplin W, Bartz J, Halpern D, Wasserman S, Wang AT, Pepa L, Tanel N, Kushki A, Hollander E. Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial. Mol Autism. 2012 Dec;3(1):16.
Hallett V, Lecavalier L, Sukhodolsky DG, Cipriano N, Aman MG, McCraken JT, McDougle CJ, Tierney E, King BH, Hollander E, Sikich L, Bregman J, Anagnostou E, Donnelly C, Katsovich L, Dukes K, Vitiello B, Gadow K, Scahill L. Exploring the Manifestations of Anxiety in Children with Autism Spectrum Disorders. J Autism Dev Disord. 2013 Feb.
Van Ameringen M, Simpson W, Patterson B, Dell'osso B, Fineberg N, Hollander E, Hranov L, Hranov G, Lochner C, Karamustafalioglu O, Marazziti D, Menchon JM, Nicolini H, Pallanti S, Stein DJ, Zohar J Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers. J Psychopharmacol. 2014 Jan 15.
Pallanti S, Bernardi S, Antonini S, Singh N, Hollander E. Ondansetron augmentation in patients with obsessive-compulsive disorder who are inadequate responders to serotonin reuptake inhibitors: Improvement with treatment and worsening following discontinuation. Eur Neuropsychopharmacol. 2013 Dec 11. pii: S0924-977X(13)00348-9. doi: 10.1016/j.euroneuro.2013.12.003. [Epub ahead of print]
Hollander E.Compulsivity and impulsivity-personal reflections: why now and why here? CNS Spectr. 2014 Feb;19(1):6-7. doi: 10.1017/S1092852913000886. Epub 2013 Nov 28.
Berlin GS, Hollander E. Compulsivity, impulsivity, and the DSM-5 process. CNS Spectr. 2014 Feb;19(1):62-8. doi: 10.1017/S1092852913000722. Epub 2013 Nov 7. Review.
Pallanti S, Hollander E.Pharmacological, experimental therapeutic, and transcranial magnetic stimulation treatments for compulsivity and impulsivity. CNS Spectr. 2014 Feb;19(1):50-61. doi: 10.1017/S1092852913000618. Epub 2013 Nov 1. Review
Benatti B, Dell'osso B, Arici C, Hollander E, Altamura AC. Characterizing impulsivity profile in patients with obsessive-compulsive disorder. Int J Psychiatry Clin Pract. 2014 Aug;18(3):156-60. doi: 10.3109/13651501.2013.855792. Epub 2013 Nov 13.
Hollander E. Social synchrony and oxytocin: from behavior to genes to therapeutics. Am J Psychiatry. 2013 Oct 1;170(10):1086-9. doi: 10.1176/appi.ajp.2013.13070848. No abstract available.
Hirota T, Veenstra-Vanderweele J, Hollander E, Kishi T. Antiepileptic Medications in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis. J Autism Dev Disord. 2014 Apr;44(4):948-57. doi: 10.1007/s10803-013-1952-2. Review.
King BH, Dukes K, Donnelly CL, Sikich L, McCracken JT, Scahill L, Hollander E, Bregman JD, Anagnostou E, Robinson F, Sullivan L, Hirtz D. Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial. JAMA Pediatr. 2013 Nov;167(11):1045-52. doi: 10.1001/jamapediatrics.2013.2698.
Dell'Osso B, Benatti B, Buoli M, Altamura AC, Marazziti D, Hollander E, Fineberg N, Stein DJ, Pallanti S, Nicolini H, Van Ameringen M, Lochner C, Hranov G, Karamustafalioglu O, Hranov L, Menchon JM, Zohar J; ICOCS group. The influence of age at onset and duration of illness on long-term outcome in patients with obsessive-compulsive disorder: a report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS). Eur Neuropsychopharmacol. 2013 Aug;23(8):865-71. doi: 10.1016/j.euroneuro.2013.05.004. Epub 2013 Jun 21.
Doyle-Thomas KA, Duerden EG, Taylor MJ, Lerch JP, Soorya LV, Wang AT, Fan J, Hollander E, Anagnostou E. Effects of age and symptomatology on cortical thickness in autism spectrum disorders. Res Autism Spectr Disord. 2013 Jan;7(1):141-150.
Pallanti S, Bernardi S, Antonini S, Singh N, Hollander E. Ondansetron augmentation in patients with obsessive-compulsive disorder who are inadequate responders to serotonin reuptake inhibitors: improvement with treatment and worsening following discontinuation.Eur Neuropsychopharmacol. 2014 Mar;24(3):375-80. doi: 10.1016/j.euroneuro.2013.12.003. Epub 2013 Dec 11.
Hollander E. Compulsivity and impulsivity-personal reflections: why now and why here? CNS Spectr. 2014 Feb;19(1):6-7. doi: 10.1017/S1092852913000886. Epub 2013 Nov 28. PMID: 24284261
Van Ameringen M, Simpson W, Patterson B, Dell'Osso B, Fineberg N, Hollander E, Hranov L, Hranov G, Lochner C, Karamustafalioglu O, Marazziti D, Menchon JM, Nicolini H, Pallanti S, Stein DJ, Zohar J. Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers. J Psychopharmacol. 2014 Jan 15;28(6):596-602. [Epub ahead of print]
Uzunova G, Hollander E, Shepherd J. The role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome. Curr Neuropharmacol. 2014 Jan;12(1):71-98. doi: 10.2174/1570159X113116660046. C.V. Eric Hollander, M.D.: Updated May 1, 2017 47
Pallanti S, Grassi G, Antonini S, Quercioli L, Salvadori E, Hollander E. rTMS in resistant mixed states: an exploratory study. J Affect Disord. 2014 Mar;157:66-71. doi: 10.1016/j.jad.2013.12.024. Epub 2013 Dec 28.
Lochner C, Fineberg NA, Zohar J, van Ameringen M, Juven-Wetzler A, Altamura AC, Cuzen NL, Hollander E, Denys D, Nicolini H, Dell'Osso B, Pallanti S, Stein DJ. Comorbidity in obsessive-compulsive disorder (OCD): a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS). Compr Psychiatry. 2014 Oct;55(7):1513-9. doi: 10.1016/j.comppsych.2014.05.020. Epub 2014 Jun 9.
Chaim CH, Nazar BP, Hollander E, Lessa JL. Pathological gambling treated with lithium: the role of assessing temperament. Addict Behav. 2014 Dec;39(12):1911-3. doi: 10.1016/j.addbeh.2014.05.016. Epub 2014 Jun 5.
Seibell PJ, Hollander E. Management of obsessive-compulsive disorder. F1000Prime Rep. 2014 Aug 1;6:68. doi: 10.12703/P6-68. eCollection 2014. Review.
Levkovitz Y, Isserles M, Padberg F, Lisanby SH, Bystritsky A, Xia G, Tendler A, Daskalakis ZJ, Winston JL, Dannon P, Hafez HM, Reti IM, Morales OG, Schlaepfer TE, Hollander E, Berman JA, Husain MM, Sofer U, Stein A, Adler S, Deutsch L, Deutsch F, Roth Y, George MS, Zangen A. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry. 2015 Feb;14(1):64-73. doi: 10.1002/wps.20199.
Bartz JA, Lydon JE, Kolevzon A, Zaki J, Hollander E, Ludwig N, Bolger N. Differential Effects of Oxytocin on Agency and Communion for Anxiously and Avoidantly Attached Individuals. Psychol Sci. 2015 Aug;26(8):1177-86. doi: 10.1177/0956797615580279. Epub 2015 Jun 29. PMID: 26122122
Simberlund J, Ferretti CJ, Hollander E. Mesenchymal stem cells in autism spectrum and neurodevelopmental disorders: pitfalls and potential promises. World J Biol Psychiatry. 2015 Jul 31:1-8. [Epub ahead of print]. PMID: 26230216
Dell'Osso B, Nicolini H, Lanzagorta N, Benatti B, Spagnolin G, Palazzo MC, Marazziti D, Hollander E, Fineberg N, Stein DJ, Pallanti S, Van Ameringen M, Lochner C, Hranov G, Karamustafalioglu O, Hranov L, Zohar J, Denys D, Altamura AC, Menchon JM. Cigarette smoking in patients with obsessive compulsive disorder: a report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS). CNS Spectr. 2015 Oct;20(5):469-73. doi: 10.1017/S1092852915000565. Epub 2015 Sep 9. PMID: 26349811
Uzunova G, Pallanti S, Hollander E. Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics. World J Biol Psychiatry. 2016, Apr. 17 (3), 174-86
Shic F, Smith D, Horsburgh B, Hollander E, Rehg JM, Goodwin M. Catalysts for Change: The Role of Small Business Funders in the Creation and Dissemination of Innovation. J Autism Dev Disord. 2015 Dec;45(12):3900-4. doi: 10.1007/s10803-015-2636-x. PMID: 26481385
Grant JE, Fineberg N, van Ameringen M, Cath D, Visser H, Carmi L, Pallanti S, Hollander E, van Balkom AJ. New treatment models for compulsive disorders. Eur Neuropsychopharmacol. 2015 Nov 18. pii: S0924-977X(15)00358-2. doi: 10.1016/j.euroneuro.2015.11.008. [Epub ahead of print] PMID: 26621260
Pallanti S, Marras A, Salerno L, Makris N, Hollander E. Better than treated as usual: Transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder, mini-review and pilot open-label trial. J Psychopharmacol. 2016 Feb 3. pii: 0269881116628427. [Epub ahead of print] PMID:26843373 C.V. Eric Hollander, M.D.: Updated May 1, 2017 48
Hunter SF, Agius M, Miller DM, Cutter G, Barbato L, McCague K, Meng X, Agashivala N, Chin P, Hollander E. Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial. J Neurol Sci. 2016 Jun 15;365:190-8. doi: 10.1016/j.jns.2016.03.024. Epub 2016 Mar 22. PMID: 27206905
Hollander E, Hong K. Relapse Prevention and Need for Ongoing Treatment in Body Dysmorphic Disorder. Am J Psychiatry, (in press).
Sara B Vasudeva, Eric Hollander, MD Body Dysmorphic Disorder in Patients with Autism Spectrum Disorder: A Reflection of Increased Local Processing and Self-Focus. Am J Psychiatry (in press).
Hollander E, Uzunova G. Are there new advances in the pharmacotherapy of autism spectrum disorders? World Psychiatry, 2017 Feb, 16(1):101-102 doi:10.1002/wps.20398
Hollander E, Doernberg E, Shavitt R, Waterman RJ, Soreni N, Veltman DJ, Sahakian BJ, Fineberg NA. The cost and impact of compulsivity: A research perspective. Eur Neuropsychopharmacol. 2016 May;26(5):800-9.
Pallanti S, Marras A, Salerno L, Makris N, Hollander E. Better than treated as usual: Transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder, mini-review and pilot open-label trial. J Psychopharmacol. 2016 Jun;30(6):568-78.
Hunter SF, Agius M, Miller DM, Cutter G, Barbato L, McCague K, Meng X, Agashivala N, Chin P, Hollander E. Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial. J Neurol Sci. 2016 Jun 15;365:190-8.
Palkar P, Kabasakalian A, Taylor B, Doernberg E, Ferretti CJ, Uzunova G, Hollander E. Behavioral phenotype in a child with Prader-Willi syndrome and comorbid 47, XYY. Intractable Rare Dis Res. 2016 Aug;5(3):235-7
Doernberg E, Hollander E. Neurodevelopmental Disorders (ASD and ADHD): DSM-5, ICD-10, and ICD-11. CNS Spectr. 2016 Aug;21(4):295-9. doi: 10.1017/S1092852916000262.
Menchón JM, van Ameringen M, Dell'Osso B, Denys D, Figee M, Grant JE, Hollander E, Marazziti D, Nicolini H, Pallanti S, Ruck C, Shavitt R, Stein DJ, Andersson E, Bipeta R, Cath DC, Drummond L, Feusner J, Geller DA, Hranov G, Lochner C, Matsunaga H, McCabe RE, Mpavaenda D, Nakamae T, O'Kearney R, Pasquini M, Pérez Rivera R, Poyurovsky M, Real E, do Rosário MC, Soreni N, Swinson RP, Vulink N, Zohar J, Fineberg N. Standards of care for obsessive-compulsive disorder centres. Int J Psychiatry Clin Pract. 2016 Sep;20(3):204-8.
Dell'Osso B, Benatti B, Hollander E, Fineberg N, Stein DJ, Lochner C, Nicolini H, Lanzagorta N, Palazzo C, Altamura AC, Marazziti D, Pallanti S, Van Ameringen M, Karamustafalioglu O, Drummond LM, Hranov L, Figee M, Grant JE, Zohar J, Denys D, Menchon JM. Childhood, adolescent and adult age at onset and related clinical correlates in obsessive-compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS). Int J Psychiatry Clin Pract. 2016 Nov;20(4):210-7.
Dell'Osso B, Benatti B, Hollander E, Altamura AC.Clinical features associated with increased severity of illness in tertiary clinic referred patients with obsessive compulsive disorder. Int J Psychiatry Clin Pract. 2016 Nov 4:1-6. [Epub ahead of print]
Umbricht D, Del Valle Rubido M, Hollander E, McCracken JT, Shic F, Scahill L, Noeldeke J, Boak L, Khwaja O, Squassante L, Grundschober C, Kletzl H, Fontoura P. A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder. Neuropsychopharmacology. 2016 Nov 16. [Epub ahead of print] C.V. Eric Hollander, M.D.: Updated May 1, 2017 49.
Mitelman SA, Bralet MC, Haznedar MM, Hollander E, Shihabuddin L, Hazlett EA, Buchsbaum MS. Diametrical relationship between gray and white matter volumes in autism spectrum disorder and schizophrenia. Brain Imaging Behav. 2016 Nov 23. [Epub ahead of print]
DellʼOsso B, Benatti B, Altamura AC, Hollander E. Prevalence of Selective Serotonin Reuptake Inhibitor-Related Apathy in Patients With Obsessive Compulsive Disorder. J Clin Psychopharmacol. 2016 Dec;36(6):725-726.
Hollander E, Uzunova G. Are there new advances in the pharmacotherapy of autism spectrum disorders? World Psychiatry. 2017 Feb;16(1):101-102.
Dell'Osso B, Benatti B, Arici C, Palazzo C, Altamura AC, Hollander E, Fineberg N, Stein DJ, Nicolini H, Lanzagorta N, Marazziti D, Pallanti S, van Ameringen M, Lochner C, Karamustafalioglu O, Hranov L, Figee M, Drummond L, Rodriguez CI, Grant J, Denys D, Menchon JM, Zohar J.Prevalence of suicide attempt and clinical characteristics of suicide attempters with obsessive-compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS). CNS Spectr. 2017 Mar 16:1-8. [Epub ahead of print]
Vasudeva SB, Hollander E. Body Dysmorphic Disorder in Patients With Autism Spectrum Disorder: A Reflection of Increased Local Processing and Self-Focus. Am J Psychiatry. 2017 Apr 1;174(4):313-316.
Mitelman SA, Bralet MC, Mehmet Haznedar M, Hollander E, Shihabuddin L, Hazlett EA, Buchsbaum MS. Positron emission tomography assessment of cerebral glucose metabolic rates in autism spectrum disorder and schizophrenia. Brain Imaging Behav. 2017 Apr 19. [Epub ahead of print]
Chiarello F, Spitoni S, Hollander E, Matucci Cerinic M, Pallanti S. An expert opinion on PANDAS/PANS: highlights and controversies. International Journal of Psychiatry in Clinical Practice. 2017 Apr 3;21(2):91-8.
Presentations (past 5 years):
Presentations are given annually at the following conferences:
- American College of Neuropsychopharmacology Annual Meeting
- Anxiety and Depression Conference (ADAA Annual Conference)
- American Psychiatric Association Annual Meeting
- iCare4Autism Meeting at Montefiore/Einstein
- Foundation for Prader-Willi Research (FPWR) Conference
- International Obsessive-Compulsive Disorder Foundation Conference:
- European College of Neuropsychopharmacology Annual Conference
- International College of Obsessive Compulsive Spectrum Disorders Meeting
- Clinical TMS Society
- Society of Biological Psychiatry